世界の細胞治療市場及びパイプラインインサイト...市場調査レポートについてご紹介

1. Introduction to Cell Therapy
1.1 Origin of Cell Therapy
1.2 The Process of Cell Therapy

2. Global Cell Therapy Market Overview
2.1 Cell Therapy Market by Segments
2.2 Cell Therapy Market by Indications
2.3 Regional Market Analysis
2.4 Market Trends
2.5 Cell Therapy Pipeline

3. Global Cell Therapy Market Dynamics
3.1 Favorable Market Drivers
3.2 Challenges to be Resolved
3.3 Future Growth Opportunity

4. Cell Therapy Key Developments
4.1 Shift from Autologous to Allogeneic Cell Therapies
4.2 Cell Collection Challenges to be Overcome
4.3 Reducing Manufacturing Risk

5. Cell Therapy Pipeline by Phase, Country & Target Indications
5.1 Research till Registration
5.2 Marketed Cell Therapy Drugs
5.3 Discontinued & Suspended

6. Pancreatic Beta Cell Replacements Therapy Pipeline by Phase, Country & Target Indications
6.1 Research till Registration
6.2 Discontinued & Suspended

7. Dopaminergic Cell Replacements Therapy Pipeline by Phase, Country & Target Indications
7.1 Research till Registration
7.2 Discontinued & Suspended

8. Competitive Landscape
8.1 Amgen
8.2 Advanced Cell Technology
8.3 Celgene Corporation
8.4 Cytomedix
8.5 California Stem Cell
8.6 Fibrocell Science
8.7 Genzyme
8.8 NeoStem
8.9 Novartis
8.10 Stemedica Cell Technologies

List of Figures

Figure 1-1: The Four Pillars of Global Pharmaceutical Industry
Figure 1-2: Composition of Cell Therapy
Figure 2-1: Global Cell Therapy Market (US$ Billion), 2012-2018
Figure 2-2: Global Cell Therapy Market by Indications, 2013
Figure 2-3: Global Cell Therapy Market by Region (%), 2013 & 2018
Figure 2-4: Global Cell Therapy Drug Pipeline by Phase(%), 2014
Figure 2-5: Global Cell Therapy Drug Pipeline by Phase (Number of Drugs), 2014
Figure 2-6: Pancreatic Beta Cell Replacement Therapy Pipeline by Phase (%), 2014
Figure 2-7: Pancreatic Beta Cell Replacement Therapy Pipeline by Phase (Number of Drugs, 2014
Figure 2-8: Dopaminergic Cell Replacement Therapy Pipeline by Phase (%), 2014
Figure 2-9: Dopaminergic Cell Replacement Therapy Pipeline by Phase (Number of Drugs), 2014

List of Tables

Following Information for Each Peptide Profile is Covered in More than 400 Tables in Report:

* Drug Profile Overview
* Active Indication
* Phase of Development
* Country for Clinical Trial
* Owner / Originator/ Licensee/Collaborator
* Administrative Route
* Drug Class